Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
MDA-MB-436
TNBC
Basal B
Cetuximab
EGFR
ErbB
7900.018
uM
inf
inf
0.5694 0.5694 0.0000 0.2033
-0.0548
0.8304
MDA-MB-415
HR+
Luminal
Selumetinib
MEK
MAPK
10938.155
uM
inf
inf
1.0500 1.0500 0.0000 -0.0500
-inf
0.5336
BT-474
HER2amp
Luminal
ICRF-193
TOP2
TOP
12056.157
uM
inf
inf
0.8491 0.8491 0.0000 0.0630
0.0552
0.9748
BT-474
HER2amp
Luminal
ICRF-193
TOP2
TOP
12291.157
uM
inf
inf
0.6757 0.6757 0.0000 0.1553
0.1959
0.5161
HCC3153
TNBC
Basal A
GW-5074
CRAF
MAPK
7466.088
uM
inf
inf
0.7503 0.7503 0.0000 0.0866
0.2768
0.9180
MDA-MB-361
HER2amp
Luminal
GM6001
MMP
MMP
7506.096
uM
inf
inf
0.9793 0.9793 0.0000 0.0173
-0.0292
1.0303
HCC2185
TNBC
Luminal
Methotrexate
DHFR
Metabolism
7463.084
uM
inf
inf
0.8941 0.8941 0.0000 0.0497
0.0064
0.7560
MDA-MB-157
TNBC
Basal B
AG1024
IGF1R
RTK
7498.066
uM
inf
inf
0.9884 0.9884 0.0000 -0.0181
-0.3947
1.0752
SUM159PT
TNBC
Basal B
GM6001
MMP
MMP
7531.096
uM
inf
inf
0.9199 0.9199 0.0000 0.0349
0.0835
3.5504
CAMA-1
HR+
Luminal
TCS PIM-1 1
Pim kinase
PIM
10755.148
uM
inf
inf
0.5279 0.5279 0.0000 0.2240
0.4039
0.6379
HCC1143
TNBC
Basal A
Cetuximab
EGFR
ErbB
7810.006
uM
inf
inf
0.8576 0.8576 0.0000 0.0064
0.5591
0.9730
HCC1187
TNBC
Basal A
Celecoxib
COX2
COX
10518.136
uM
inf
inf
0.9091 0.9091 0.0000 0.0220
0.1805
1.2490
HCC1187
TNBC
Basal A
Cetuximab
EGFR
ErbB
7811.018
uM
inf
inf
0.6946 0.6946 0.0000 0.1308
-0.0060
0.4694
HCC1187
TNBC
Basal A
Cetuximab
EGFR
ErbB
7812.042
uM
inf
inf
0.5614 0.5614 0.0000 0.0267
0.3674
0.9722
BT-474
HER2amp
Luminal
JNK-IN-5A
JNK
JNK
12178.144
uM
inf
inf
0.6802 0.6802 0.0000 0.1793
-0.0043
0.7891
BT-474
HER2amp
Luminal
JNK-IN-5A
JNK
JNK
12056.144
uM
inf
inf
0.8442 0.8442 0.0000 0.0965
0.2228
0.9738
AU565
HER2amp
Luminal
Cetuximab
EGFR
ErbB
9146.122
uM
inf
inf
0.9694 0.9694 0.0000 -0.0404
-1.9847
1.3408
HCC1806
TNBC
Basal A
Pemetrexed
TYMS/DHFR/GARFT
TYMS
7451.095
uM
inf
inf
0.7452 0.7452 0.0000 0.2906
0.3518
2.2028
HCC1954
HER2amp
Basal A
TPCA-1
IKK
NFKB
7454.093
uM
inf
inf
0.7670 0.7670 0.0000 0.2123
-0.1144
1.3347
BT-474
HER2amp
Luminal
L-779450
BRAF
MAPK
12291.166
uM
inf
inf
0.1392 0.1392 0.0000 0.2732
0.4769
0.5962
184B5
NM
Basal
Sirolimus
MTOR
MTOR
7789.068
uM
inf
inf
-0.9304 -0.9304 0.0000 1.0723
0.4470
0.3219
AU565
HER2amp
Luminal
Cetuximab
EGFR
ErbB
7793.018
uM
inf
inf
0.9318 0.9318 0.0000 0.0067
0.3477
1.3186
HCC1187
TNBC
Basal A
Dactolisib
PI3K
PI3K
10753.146
uM
inf
inf
0.7845 0.7845 0.0000 0.1084
0.4052
1.4503
HCC1187
TNBC
Basal A
Dichloroacetate
PDK
PDK
13726.176
uM
inf
inf
0.6786 0.6786 0.0000 0.3517
-0.3654
0.4071
HCC1143
TNBC
Basal A
Cetuximab
EGFR
ErbB
7809.018
uM
inf
inf
0.9659 0.9659 0.0000 -0.0257
-0.2331
1.6742